Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
British Journal of Cancer|October 6, 2012
International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomyL-M Wong, D E Neal, R B Johnston, et al.
Cancer Causes & Control : CCC|January 4, 2021
Men's experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative studyE Sutton, J A Lane, M Davis, et al.
British Journal of Cancer|September 13, 2012
Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urineK Saeb-Parsy, A Wilson, C Scarpini, et al.
British Journal of Cancer|July 25, 2013
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stressH C Whitaker, D Patel, W J Howat, et al.
European Journal of Clinical Nutrition|September 29, 2016
Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diariesJ A Lane, S E Oliver, P N Appleby, et al.
Oncogene|November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotypeH C Whitaker, L L Shiong, J D Kay, et al.
Scientific Reports|July 19, 2017
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder CancerK M Patel, K E van der Vos, C G Smith, et al.
Health Technology Assessment (Winchester, England)|November 7, 2012
Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancerC Ramsay, R Pickard, C Robertson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2015
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesZ Kote-Jarai, C Mikropoulos, D A Leongamornlert, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
Pageof 24